GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » COGS-to-Revenue

Awakn Life Sciences (Awakn Life Sciences) COGS-to-Revenue : 0.00 (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences COGS-to-Revenue?

Awakn Life Sciences's Cost of Goods Sold for the three months ended in Jan. 2024 was $0.00 Mil. Its Revenue for the three months ended in Jan. 2024 was $0.02 Mil.

Awakn Life Sciences's COGS to Revenue for the three months ended in Jan. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Awakn Life Sciences's Gross Margin % for the three months ended in Jan. 2024 was N/A%.


Awakn Life Sciences COGS-to-Revenue Historical Data

The historical data trend for Awakn Life Sciences's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences COGS-to-Revenue Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23 Jan24
COGS-to-Revenue
- 2.17 - -

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.84 - - -

Awakn Life Sciences COGS-to-Revenue Calculation

Awakn Life Sciences's COGS to Revenue for the fiscal year that ended in Jan. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0.065
=0.00

Awakn Life Sciences's COGS to Revenue for the quarter that ended in Jan. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0.016
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Awakn Life Sciences  (OTCPK:AWKNF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Awakn Life Sciences's Gross Margin % for the three months ended in Jan. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0.016
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Awakn Life Sciences COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences (Awakn Life Sciences) Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines